期刊文献+

小细胞肺癌患者抑郁状态与Th1/Th2型细胞因子相关性的初步研究 被引量:4

Relationship Between Depression and Serum Levels of Th1/Th2 Cytokines from Patients with Small Cell Lung Cancer
原文传递
导出
摘要 目的:探讨小细胞肺癌患者抑郁状态与辅助性T细胞(Th)1/Th2型细胞因子之间的关系。方法:选择小细胞肺癌患者91例,按照汉密尔顿抑郁量表(HAMD)评分标准分为抑郁组41例和无抑郁组50例,并设立健康对照组。用酶联免疫吸附法(ELISA)检测患者外周血中Th1型细胞因子白细胞介素2(IL-2)、干扰素γ(IFN-γ)和Th2型细胞因子白细胞介素4(IL-4)、白细胞介素10(IL-10)的浓度。结果:小细胞肺癌患者外周血中IL-2、IFN-γ水平较健康组明显下降,IL-4I、L-10水平较健康组显著升高。而与无抑郁组比较,抑郁组外周血中IL-2、IFN-γ水平下降更为明显,IL-4I、L-10水平升高更为显著。结论:小细胞肺癌患者外周血中的Th1/Th2型细胞因子明显失衡,细胞免疫功能低下,尤其是伴有抑郁障碍者细胞免疫功能低下更为显著。因此,尽早识别和治疗小细胞肺癌伴抑郁障碍者具有重要意义。 Objective. To investigate the relationship between the depression and the levels of Th1/Th2 cyto- kines in serum from patients with small cell lung cancer. Methods. Ninety-one patients with small cell lung cancer were divided into depression group (n=41) and nowdepression group (n=50) according to the Hamilton depression scale(HAMD). The interleukin-2 (IL-2), interferon-γ(IFN-γ), interleukin 4 (IL-4) and interleukin 10 (IL-10) in serum were determined by enzymeqinked immunosorbent assay (ELISA). Results. Compared with that of healthy control group and the non-depression group, the levels of IL-2 and IFN-γ in serum from patients of depression group were decreased significantly, and the levels of IL-4 and IL-10 were increased significantly. Compared with that of non-depression group, the levels of IL-2 and IFN-γ in serum from the patients of depression group were decreased more significant- ly, the levels of IL-4 and IL-10 were more significantly increased. ConclusionThe levels of Th1/Th2 cytokines in serum from the patients of depression group are more significantly imbalanced than that of non-depression group. It is very important for us to diagnose and to treat the depression of patients with small cell lung cancer as early as possible.
出处 《武汉大学学报(医学版)》 CAS 2008年第6期810-813,共4页 Medical Journal of Wuhan University
关键词 小细胞肺癌 抑郁 TH1细胞 TH2细胞 细胞因子 Small Cell Lung Cancer Depression T Helper Cells Cytokine
  • 相关文献

参考文献13

  • 1毛佩贤,贺佳丽,蔡焯基,刘哲,张成敏,朱允中,李诚民.肺癌患者抑郁状态的相关因素分析[J].中国心理卫生杂志,2000,14(6):417-419. 被引量:74
  • 2Ashbury FD, Madlensky L, Raich P, et al. Antidepressant prescribing in community cancer care[J]. Support Care Cancer, 2003,11(5):278-285.
  • 3Uchitomi Y, Mikai I, Nagai K, et al. Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer[J]. J Clin Oncol, 2003,21(1) :69-77.
  • 4Abernethy AD, Chang HT, Seidlitz L, et al. Religious coping and depression among spouses of people with lung cancer [J]. Psychosomatics, 2002, 43 ( 6 ) : 456- 463.
  • 5Neuner A, Schindel M, Wildenberg U, et al. Cytokine secretion: clinical relevance of immunosuppression in non-snail cell lung cancer[J]. Lung Cancer, 2001,34 (suppl2) : S79-S82.
  • 6Chen YM, Yang WK,Whang PJ, et al. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer[J]. Lung Cancer. 2001,31(1) :25-30.
  • 7Neuner A,Schindel M, Wildenberg U, et al. Prognostic significance of cytokine modulation in non-small lung cancer[J]. IntJ Cancer,2002,101(3):287-292.
  • 8Carter PA. Caregivers' descriptions of sleep changes and depressive symptoms[J]. Oncol Nurs Forum, 2002,29(9) :1277-1283.
  • 9汪向东 王希林 等.心理卫生评定量表手册(增订版)[J].中国心理卫生杂志,1999,:31-130.
  • 10郭克锋,杨文清,白宪光,王秉康.心理行为疾病的临床特征与康复[J].中国临床康复,2002,6(21):3149-3150. 被引量:19

二级参考文献25

  • 1Ito N, Nakamura H, Metsugi H, et al. Dissociation between T helper type 1 and type 2 differentiation and cytokine production in tumorinfiltrating lymphocytes in patients with lung cancer. Surg Today,2001,31(5): 390-394.
  • 2Mroczko B, Szmitkowski M, Czygier M. Granulocyte colony stimulating factor (G-CSF) in diagnosis and monitoring of non-small-cell lung cancer (NSCLC) . Pol Arch Med Wewn, 2000, 103(3-4):163-168.
  • 3Yasuoka Y, Naomoto Y, Yamatsuji T, et al. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Exp Cell Res, 2001,271 (2):214-222.
  • 4Pluygers E, Sadowska A, Chyczewski L, et al. The impact of immune responses on lung cancer and the development of new treatment modalities. Lung Cancer, 2001,34( Suppl 2): S71-77.
  • 5Nekhaev Ⅳ, Sviridova SP, Kiselevskii MV. Possibilities of immune prevention of pyo-septic complications in cancer patients by granulocytic colony stimulating factors. Anesteziol Reanimatol, 2001 , (5):64-67.
  • 6Zhu LX, Sharma S, Gardner B, et al. IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol,2003,170(7): 3585-3591.
  • 7Takeuchi E, Yanagawa H, Suzuki Y, et al . IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions. Lung Cancer,2002 ,35(2): 171-177.
  • 8Sabatini F, Silvestri M, Sale R, et al. Cytokine release and adhesion molecule expression by stimulated human bronchial epithelial cells are downregulated by salmeterol. Respir Med, 2003, 97 ( 9 ): 1052-1060.
  • 9Neuner A, Schindel M, Wildenberg U, et al. Cytokine secretion:clinical relevance of immunosuppression in non-small cell lung cancer. Lung Cancer, 2001, 34 (Suppl 2): S79-82.
  • 10Chen YM, Yang WK, Whang Peng J, et al. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer, 2001,31 ( 1 ) :25-30.

共引文献700

同被引文献82

引证文献4

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部